PLK1 and neoplasm: The final results indicated that PLK1 is a potent prognostic biomarker for LA and that PLK1 probably inhibits tumor immune infiltration and thus promote proliferation and metastasis of LA cells through inhibiting necroptosis (Fig. 1).